7 October 2024
The All Wales Therapeutics and Toxicology Centre (AWTTC) are pleased to announce publication of the Individual Patient Funding Request (IPFR) annual report for 2023 – 2024.
Compiled by AWTTC the report highlights the work of the IPFR teams across all Welsh Health Boards and the NHS Wales Joint Commissioning Committee (formerly Welsh Health Specialised Services Committee).
In 2023-2024 IPFR teams across Wales have continued to provide a vital service for patients who may require treatments not routinely available in NHS Wales. The teams work hard to ensure that IPFRs are considered in a timely and consistent manner and that decision-making is fair and transparent. Highlighted in the report:
An IPFR is defined as ‘a request to a health board or the Joint Commissioning Committee to fund NHS healthcare for an individual patient whose needs fall outside the range of services and treatments that a health board has arranged to routinely provide’.
Further information about the IPFR service in Wales can be found on the AWTTC website.
Prof James Coulson, Clinical Director, AWTTC said: “As Chair of the IPFR Quality Assurance process I am heartened to see continued improvements in the application process at a local level…. It is excellent to see local panel initiatives to develop and improve IPFR service provision and we wish all the panels in Wales continued success in the coming year.”
In 2023-2024 health boards in Wales recruited and trained a combined five new panel members. Several panels are still looking to recruit new members or deputy members.
For information on becoming a lay member please visit the AWTTC website.
For information on panel vacancies for healthcare professionals please contact your local health board IPFR team.